TREM2 drives accumulation of pro-scarring monocyte-derived macrophages in the infarcted myocardium
This study demonstrates that TREM2 is essential for the accumulation and pro-fibrotic function of monocyte-derived macrophages in the infarcted myocardium, where it drives scar formation by promoting efferocytosis-induced gene expression and fibroblast activation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
When the heart suffers a heart attack, a sudden blockage cuts off its blood supply, causing heart muscle cells to die. The body's immediate response is to send in a cleanup crew: white blood cells called macrophages. These cells act as the immune system's sanitation workers, swallowing up the dead tissue and debris left behind by the injury. But their job does not end with cleaning. To prevent the heart from collapsing or rupturing, the body must build a strong scar over the damaged area. This process relies on a delicate balance. If the scar is too weak, the heart fails; if it is too thick or stiff, the heart cannot pump blood effectively. For years, scientists have known that macrophages are essential for building this scar, but the specific instructions they follow and the signals they use to coordinate with the cells that build the scar have remained largely a mystery.
A team of researchers has now uncovered a critical piece of this puzzle, focusing on a specific protein called TREM2 found on the surface of certain macrophages. In a study published recently, the scientists discovered that TREM2 acts as a master switch that tells these immune cells to transform into a specialized workforce dedicated to scar formation. Without this protein, the heart's repair crew fails to gather in sufficient numbers, and the resulting scar is weaker and larger than it should be. This finding clarifies how the immune system communicates with the heart's structural cells to heal a wound, revealing a mechanism that could one day help doctors guide the healing process more effectively after a heart attack.
The researchers began by looking at the heart of mice that had suffered a heart attack, using advanced tools to map out every cell type present in the damaged tissue over time. They found that shortly after the injury, a specific group of macrophages arrived in large numbers. These cells were distinct because they carried high levels of the TREM2 protein. By examining the genetic activity of these cells, the team realized they were not just cleaning up; they were actively preparing to build a scar. These TREM2-rich cells were found living right next to myofibroblasts, which are the specialized cells responsible for producing the tough, fibrous material that makes up a scar. The two cell types were so close together that they appeared to be working in a tight partnership, with the macrophages likely sending signals to tell the myofibroblasts when to start building.
To understand exactly what TREM2 was doing, the scientists compared the hearts of normal mice with those of mice that lacked the gene for TREM2. In the mice without TREM2, the researchers observed a significant problem: the specialized macrophages that usually gather to help build the scar did not accumulate in the heart. Because these cells were missing, the myofibroblasts did not receive the necessary signals to multiply and produce collagen, the main building block of the scar. As a result, the hearts of the mice without TREM2 developed larger, weaker scars. While the lack of TREM2 did reduce some of the excessive scarring that can occur in healthy tissue surrounding the injury, the overall effect was negative. The primary scar that formed over the heart attack site was insufficient to hold the heart together, leading to a larger area of damage. This showed that TREM2 is essential for the proper formation of the scar that protects the heart.
The team then moved to the laboratory to figure out how these cells knew to start building. They knew that macrophages in the heart are constantly eating dead cells, a process called efferocytosis. They tested whether this act of cleaning up dead cells was the trigger that turned on the scar-building program. When they exposed immune cells to dead cells in a dish, the cells immediately began producing genes associated with scar formation. However, this transformation was much stronger when the cells were also exposed to a specific chemical signal called IL-4, which is present in the heart after an injury. The researchers found that the combination of eating dead cells and receiving the IL-4 signal created a powerful effect, driving the macrophages to produce a specific set of proteins that tell fibroblasts to move and multiply.
Crucially, the study showed that the protein TREM2 is required for this process to work. When the researchers blocked TREM2 in the lab, the macrophages could still eat the dead cells, but they failed to produce the proteins needed to activate the fibroblasts. One of the most important proteins identified in this chain of events was GPNMB. The researchers found that TREM2 was necessary for the macrophages to produce GPNMB, and without it, the fibroblasts did not receive the call to action. This suggests that TREM2 acts as a bridge, translating the act of cleaning up dead tissue into the construction of a new scar. The study also confirmed that this process is not unique to mice; similar patterns of TREM2-rich cells were found in heart tissue samples from human patients who had suffered heart attacks, indicating that this repair mechanism is conserved across species.
The findings paint a clear picture of a highly coordinated repair system. After a heart attack, the heart sends out a call for help. Macrophages arrive to clear the debris, and as they do so, they are guided by TREM2 to switch from a cleanup mode to a construction mode. They then release specific chemical signals that wake up the heart's structural cells, telling them to build a scar that is strong enough to save the heart but not so stiff that it hinders its function. Without TREM2, this conversation breaks down. The cleanup crew arrives, but they do not know how to start the construction, leaving the heart vulnerable. This research does not offer an immediate cure, but it provides a fundamental understanding of how the heart heals itself. By identifying the specific protein and the signals involved, scientists now have a clearer view of the biological machinery that determines whether a heart attack leads to a life-saving scar or a life-threatening failure.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.